{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T12:58:32Z","timestamp":1780577912154,"version":"3.54.1"},"reference-count":109,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T00:00:00Z","timestamp":1597363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Genome-wide association studies (GWAS) are useful in assessing and analyzing either differences or variations in DNA sequences across the human genome to detect genetic risk factors of diseases prevalent within a target population under study. The ultimate goal of GWAS is to predict either disease risk or disease progression by identifying genetic risk factors. These risk factors will define the biological basis of disease susceptibility for the purposes of developing innovative, preventative, and therapeutic strategies. As single nucleotide polymorphisms (SNPs) are often used in GWAS, their relevance for triple negative breast cancer (TNBC) will be assessed in this review. Furthermore, as there are different levels and patterns of linkage disequilibrium (LD) present within different human subpopulations, a plausible strategy to evaluate known SNPs associated with incidence of breast cancer in ethnically different patient cohorts will be presented and discussed. Additionally, a description of GWAS for TNBC will be presented, involving various identified SNPs correlated with miRNA sites to determine their efficacies on either prognosis or progression of TNBC in patients. Although GWAS have identified multiple common breast cancer susceptibility variants that individually would result in minor risks, it is their combined effects that would likely result in major risks. Thus, one approach to quantify synergistic effects of such common variants is to utilize polygenic risk scores. Therefore, studies utilizing predictive risk scores (PRSs) based on known breast cancer susceptibility SNPs will be evaluated. Such PRSs are potentially useful in improving stratification for screening, particularly when combining family history, other risk factors, and risk prediction models. In conclusion, although interpretation of the results from GWAS remains a challenge, the use of SNPs associated with TNBC may elucidate and better contextualize these studies.<\/jats:p>","DOI":"10.3390\/ijms21165835","type":"journal-article","created":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T08:28:35Z","timestamp":1597393715000},"page":"5835","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Critical Analysis of Genome-Wide Association Studies: Triple Negative Breast Cancer Quae Exempli Causa"],"prefix":"10.3390","volume":"21","author":[{"given":"Maria-Ancuta","family":"Jurj","sequence":"first","affiliation":[{"name":"Research Center for Functional Genomics, Biomedicine and Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, 400337 Cluj-Napoca, Cluj, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8372-9961","authenticated-orcid":false,"given":"Mihail","family":"Buse","sequence":"additional","affiliation":[{"name":"MEDFUTURE Research Center for Advanced Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, 400337 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3856-3784","authenticated-orcid":false,"given":"Alina-Andreea","family":"Zimta","sequence":"additional","affiliation":[{"name":"MEDFUTURE Research Center for Advanced Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, 400337 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6495-2295","authenticated-orcid":false,"given":"Angelo","family":"Paradiso","sequence":"additional","affiliation":[{"name":"Laboratorio Oncologia Sperimentale Clinica, Istituto Oncologico-Bari, I-70124 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Schuyler S.","family":"Korban","sequence":"additional","affiliation":[{"name":"Department of Natural Resources and Environmental Sciences, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5806-0220","authenticated-orcid":false,"given":"Laura-Ancuta","family":"Pop","sequence":"additional","affiliation":[{"name":"Research Center for Functional Genomics, Biomedicine and Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, 400337 Cluj-Napoca, Cluj, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5828-1325","authenticated-orcid":false,"given":"Ioana","family":"Berindan-Neagoe","sequence":"additional","affiliation":[{"name":"Research Center for Functional Genomics, Biomedicine and Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, 400337 Cluj-Napoca, Cluj, Romania"},{"name":"Department of Functional Genomics and Experimental Pathology, The Oncology Institute \u201cProf. Dr. I Chiricuta\u201d, 400015 Cluj-Napoca, Cluj, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,8,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Genomes Project Consortium, Auton, A., Brooks, L.D., Durbin, R.M., Garrison, E.P., Kang, H.M., Korbel, J.O., Marchini, J.L., McCarthy, S., and McVean, G.A. (2015). A global reference for human genetic variation. Nature, 526, 68\u201374.","DOI":"10.1038\/nature15393"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Bush, W.S., and Moore, J.H. (2012). Chapter 11: Genome-wide association studies. PLoS Comput. Biol., 8.","DOI":"10.1371\/journal.pcbi.1002822"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Mavaddat, N., Pharoah, P.D., Michailidou, K., Tyrer, J., Brook, M.N., Bolla, M.K., Wang, Q., Dennis, J., Dunning, A.M., and Shah, M. (2015). Prediction of breast cancer risk based on profiling with common genetic variants. J. Natl. Cancer Inst., 107.","DOI":"10.1093\/jnci\/djv036"},{"key":"ref_4","first-page":"831460","article-title":"SNP discovery through next-generation sequencing and its applications","volume":"2012","author":"Kumar","year":"2012","journal-title":"Int. J. Plant Genom."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/nrg2361","article-title":"Linkage disequilibrium\u2014Understanding the evolutionary past and mapping the medical future","volume":"9","author":"Slatkin","year":"2008","journal-title":"Nat. Rev. Genet."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0022-5193(88)80056-0","article-title":"Epigenetic selection: An alternative mechanism of pattern formation","volume":"134","author":"Sachs","year":"1988","journal-title":"J. Theor. Biol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1038\/nature05887","article-title":"Genome-wide association study identifies novel breast cancer susceptibility loci","volume":"447","author":"Easton","year":"2007","journal-title":"Nature"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0168-9525(01)02410-6","article-title":"On the allelic spectrum of human disease","volume":"17","author":"Reich","year":"2001","journal-title":"Trends Genet. TIG"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.cell.2010.03.032","article-title":"Genetic heterogeneity in human disease","volume":"141","author":"McClellan","year":"2010","journal-title":"Cell"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.cell.2010.07.025","article-title":"Strategies for genetic studies of complex diseases","volume":"142","author":"Wang","year":"2010","journal-title":"Cell"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.cell.2010.07.026","article-title":"Successes of genome-wide association studies","volume":"142","author":"Klein","year":"2010","journal-title":"Cell"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2217\/14622416.10.2.191","article-title":"Meta-analysis in genome-wide association studies","volume":"10","author":"Zeggini","year":"2009","journal-title":"Pharmacogenomics"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev-genom-091212-153520","article-title":"The power of meta-analysis in genome-wide association studies","volume":"14","author":"Panagiotou","year":"2013","journal-title":"Annu. Rev. Genom. Hum. Genet."},{"key":"ref_14","first-page":"1521","article-title":"GWAR: Robust analysis and meta-analysis of genome-wide association studies","volume":"33","author":"Dimou","year":"2017","journal-title":"Bioinformatics (Oxford, England)"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nrg3472","article-title":"Meta-analysis methods for genome-wide association studies and beyond","volume":"14","author":"Evangelou","year":"2013","journal-title":"Nat. Rev. Genet."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/ng.2561","article-title":"Genome-wide association studies identify four ER negative-specific breast cancer risk loci","volume":"45","author":"Couch","year":"2013","journal-title":"Nat. Genet."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/ng.2560","article-title":"Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array","volume":"45","author":"Eeles","year":"2013","journal-title":"Nat. Genet."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/ng.2564","article-title":"GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer","volume":"45","author":"Pharoah","year":"2013","journal-title":"Nat. Genet."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/ng.2563","article-title":"Large-scale genotyping identifies 41 new loci associated with breast cancer risk","volume":"45","author":"Michailidou","year":"2013","journal-title":"Nat. Genet."},{"key":"ref_20","unstructured":"Consortium, T.B.C.A. (2020, July 10). BCAC. Available online: http:\/\/bcac.ccge.medschl.cam.ac.uk\/."},{"key":"ref_21","unstructured":"Brigham, M.G. (2020, July 10). ISC. Available online: https:\/\/www.massgeneral.org\/."},{"key":"ref_22","unstructured":"(2020, July 10). MAGIC Consortium. Available online: https:\/\/www.magicinvestigators.org\/."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nrc.2017.82","article-title":"Genome-wide association studies of cancer: Current insights and future perspectives","volume":"17","author":"Sud","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"ref_24","unstructured":"(2020, July 10). Globocan Breast Worldwide. Available online: https:\/\/gco.iarc.fr\/."},{"key":"ref_25","unstructured":"(2020, July 10). Globocan Breast Romania. Available online: https:\/\/gco.iarc.fr\/."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/sj.bjc.6602787","article-title":"Clinical characteristics of different histologic types of breast cancer","volume":"93","author":"Li","year":"2005","journal-title":"Br. J. Cancer"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/ajcp\/104.6.614","article-title":"Recommendations for the reporting of breast carcinoma. Association of Directors of Anatomic and Surgical Pathology","volume":"104","author":"Connolly","year":"1995","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.5858\/133.10.1515","article-title":"Protocol for the examination of specimens from patients with invasive carcinoma of the breast","volume":"133","author":"Lester","year":"2009","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.gdata.2017.01.002","article-title":"Genome-wide chromatin accessibility, DNA methylation and gene expression analysis of histone deacetylase inhibition in triple-negative breast cancer","volume":"12","author":"Bustos","year":"2017","journal-title":"Genom. Data"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"10869","DOI":"10.1073\/pnas.191367098","article-title":"Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications","volume":"98","author":"Sorlie","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"8418","DOI":"10.1073\/pnas.0932692100","article-title":"Repeated observation of breast tumor subtypes in independent gene expression data sets","volume":"100","author":"Sorlie","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","article-title":"Molecular portraits of human breast tumours","volume":"406","author":"Perou","year":"2000","journal-title":"Nature"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1093\/annonc\/mdp492","article-title":"Triple-negative breast cancer\u2014Current status and future directions","volume":"20","author":"Gluz","year":"2009","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1017\/erm.2016.17","article-title":"Novel insight into triple-negative breast cancers, the emerging role of angiogenesis, and antiangiogenic therapy","volume":"18","author":"Braicu","year":"2016","journal-title":"Expert Rev. Mol. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.breast.2017.11.006","article-title":"Genetic alterations in sporadic triple negative breast cancer","volume":"38","author":"Pop","year":"2018","journal-title":"Breast"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/nrclinonc.2010.154","article-title":"Triple-negative breast cancer: Disease entity or title of convenience?","volume":"7","author":"Carey","year":"2010","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1158\/1078-0432.CCR-06-3045","article-title":"Triple-negative breast cancer: Clinical features and patterns of recurrence","volume":"13","author":"Dent","year":"2007","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1200\/JCO.2007.14.4147","article-title":"Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer","volume":"26","author":"Liedtke","year":"2008","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1056\/NEJMra1001389","article-title":"Triple-negative breast cancer","volume":"363","author":"Foulkes","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"3239167","DOI":"10.1155\/2016\/3239167","article-title":"Blood genome-wide transcriptional profiles of HER2 negative breast cancers patients","volume":"2016","author":"Balacescu","year":"2016","journal-title":"Mediat. Inflamm."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1016\/S0140-6736(16)32454-0","article-title":"Molecular alterations in triple-negative breast cancer-the road to new treatment strategies","volume":"389","author":"Denkert","year":"2017","journal-title":"Lancet (London, England)"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1093\/annonc\/mdz012","article-title":"OlympiAD final overall survival and tolerability results: Olaparib versus chemotherapy treatment of physician\u2019s choice in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer","volume":"30","author":"Robson","year":"2019","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1056\/NEJMoa1802905","article-title":"Talazoparib in patients with advanced breast cancer and a germline BRCA mutation","volume":"379","author":"Litton","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13058-018-1085-9","article-title":"Identification of novel common breast cancer risk variants at the 6q25 locus among Latinas","volume":"21","author":"Hoffman","year":"2019","journal-title":"Breast Cancer Res. BCR"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S1470-2045(17)30167-5","article-title":"Common genetic variation and risk of gallbladder cancer in India: A case-control genome-wide association study","volume":"18","author":"Mhatre","year":"2017","journal-title":"Lancet Oncol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"40963","DOI":"10.1038\/srep40963","article-title":"Association of Genome-Wide Association Study (GWAS) identified SNPs and risk of breast cancer in an indian population","volume":"7","author":"Nagrani","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1158\/1078-0432.CCR-15-1746","article-title":"Association between GWAS-derived rs966423 genetic variant and overall mortality in patients with differentiated thyroid cancer","volume":"22","author":"Swierniak","year":"2016","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Kang, B.W., Jeon, H.S., Chae, Y.S., Lee, S.J., Park, J.Y., Choi, J.E., Park, J.S., Choi, G.S., and Kim, J.G. (2015). Association between GWAS-identified genetic variations and disease prognosis for patients with colorectal cancer. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0119649"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1002\/ijc.29446","article-title":"Association of breast cancer risk loci with breast cancer survival","volume":"137","author":"Barrdahl","year":"2015","journal-title":"Int. J. Cancer"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1634\/theoncologist.2012-0419","article-title":"The relationship between eight GWAS-identified single-nucleotide polymorphisms and primary breast cancer outcomes","volume":"18","author":"Bayraktar","year":"2013","journal-title":"Oncologist"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nrg1327","article-title":"Genomic variants in exons and introns: Identifying the splicing spoilers","volume":"5","author":"Pagani","year":"2004","journal-title":"Nat. Rev. Genet."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3389\/fcvm.2018.00181","article-title":"Into the wild: GWAS exploration of non-coding RNAs","volume":"5","author":"Giral","year":"2018","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/bcr2224","article-title":"Transforming growth factor-beta in breast cancer: Too much, too late","volume":"11","author":"Akhurst","year":"2009","journal-title":"Breast Cancer Res. BCR"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.3892\/ijo.2016.3474","article-title":"Unusual roles of caspase-8 in triple-negative breast cancer cell line MDA-MB-231","volume":"48","author":"Morreale","year":"2016","journal-title":"Int. J. Oncol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/ng1981","article-title":"A common coding variant in CASP8 is associated with breast cancer risk","volume":"39","author":"Cox","year":"2007","journal-title":"Nat. Genet."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Skeeles, L.E., Fleming, J.L., Mahler, K.L., and Toland, A.E. (2013). The impact of 3\u2019UTR variants on differential expression of candidate cancer susceptibility genes. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0058609"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S1470-2045(11)70044-4","article-title":"A 3\u2032-untranslated region KRAS variant and triple-negative breast cancer: A case-control and genetic analysis","volume":"12","author":"Paranjape","year":"2011","journal-title":"Lancet Oncol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.tig.2014.04.006","article-title":"Exposing synonymous mutations","volume":"30","author":"Hunt","year":"2014","journal-title":"Trends Genet. TIG"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"4442","DOI":"10.1093\/hmg\/ddp372","article-title":"Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers","volume":"18","author":"Antoniou","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/carcin\/bgs093","article-title":"Evaluation of 19 susceptibility loci of breast cancer in women of African ancestry","volume":"33","author":"Huo","year":"2012","journal-title":"Carcinogenesis"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/cncr.30498","article-title":"A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes","volume":"123","author":"Buys","year":"2017","journal-title":"Cancer"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1200\/JCO.2014.57.1414","article-title":"Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer","volume":"33","author":"Couch","year":"2015","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/ejhg.2008.212","article-title":"Breast cancer susceptibility: Current knowledge and implications for genetic counselling","volume":"17","author":"Ripperger","year":"2009","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ng.2007.53","article-title":"The emerging landscape of breast cancer susceptibility","volume":"40","author":"Stratton","year":"2008","journal-title":"Nat. Genet."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"4382606","DOI":"10.1155\/2019\/4382606","article-title":"A review of the hereditary component of triple negative breast cancer: High- and moderate-penetrance breast cancer genes, low-penetrance loci, and the role of nontraditional genetic elements","volume":"2019","author":"Ellsworth","year":"2019","journal-title":"J. Oncol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"R102","DOI":"10.1093\/hmg\/ddv259","article-title":"Non-coding genetic variants in human disease","volume":"24","author":"Zhang","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.tig.2016.10.008","article-title":"Mining the unknown: Assigning function to noncoding single nucleotide polymorphisms","volume":"33","author":"Nishizaki","year":"2017","journal-title":"Trends Genet. TIG"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nrc1997","article-title":"MicroRNA signatures in human cancers","volume":"6","author":"Calin","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Moszynska, A., Gebert, M., Collawn, J.F., and Bartoszewski, R. (2017). SNPs in microRNA target sites and their potential role in human disease. Open Biol., 7.","DOI":"10.1098\/rsob.170019"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/humu.21641","article-title":"Genome-wide identification of SNPs in microRNA genes and the SNP effects on microRNA target binding and biogenesis","volume":"33","author":"Gong","year":"2012","journal-title":"Hum. Mutat."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/nature05939","article-title":"A microRNA component of the p53 tumour suppressor network","volume":"447","author":"He","year":"2007","journal-title":"Nature"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1093\/carcin\/bgn126","article-title":"Polymorphisms in predicted microRNA-binding sites in integrin genes and breast cancer: ITGB4 as prognostic marker","volume":"29","author":"Brendle","year":"2008","journal-title":"Carcinogenesis"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrc1840","article-title":"Oncomirs\u2014MicroRNAs with a role in cancer","volume":"6","author":"Slack","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.gene.2015.10.019","article-title":"Association of the microRNA-Single Nucleotide Polymorphism rs2910164 in miR146a with sporadic breast cancer susceptibility: A case control study","volume":"576","author":"Upadhyaya","year":"2016","journal-title":"Gene"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1007\/s00439-016-1707-1","article-title":"Genetic variants in microRNA and microRNA biogenesis pathway genes and breast cancer risk among women of African ancestry","volume":"135","author":"Qian","year":"2016","journal-title":"Hum. Genet."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1093\/carcin\/bgs172","article-title":"Polymorphisms in miRNA-binding sites of nucleotide excision repair genes and colorectal cancer risk","volume":"33","author":"Naccarati","year":"2012","journal-title":"Carcinogenesis"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Mullany, L.E., Wolff, R.K., Herrick, J.S., Buas, M.F., and Slattery, M.L. (2015). SNP Regulation of microRNA Expression and Subsequent Colon Cancer Risk. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0143894"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1158\/0008-5472.CAN-09-3541","article-title":"Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility","volume":"70","author":"Nicoloso","year":"2010","journal-title":"Cancer Res."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Khan, S., Greco, D., Michailidou, K., Milne, R.L., Muranen, T.A., Heikkinen, T., Aaltonen, K., Dennis, J., Bolla, M.K., and Liu, J. (2014). MicroRNA related polymorphisms and breast cancer risk. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0109973"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1158\/0008-5472.CAN-07-5991","article-title":"Evaluation of genetic variants in microRNA-related genes and risk of bladder cancer","volume":"68","author":"Yang","year":"2008","journal-title":"Cancer Res."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1093\/carcin\/bgn116","article-title":"Polymorphisms in microRNA targets: A gold mine for molecular epidemiology","volume":"29","author":"Chen","year":"2008","journal-title":"Carcinogenesis"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.pharmthera.2012.08.016","article-title":"SNPing cancer in the bud: microRNA and microRNA-target site polymorphisms as diagnostic and prognostic biomarkers in cancer","volume":"137","author":"Salzman","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Wilk, G., and Braun, R. (2018). regQTLs: Single nucleotide polymorphisms that modulate microRNA regulation of gene expression in tumors. PLoS Genet., 14.","DOI":"10.1371\/journal.pgen.1007837"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"36906","DOI":"10.18632\/oncotarget.26385","article-title":"Evaluation of pre-mir-34a rs72631823 single nucleotide polymorphism in triple negative breast cancer: A case-control study","volume":"9","author":"Kalapanida","year":"2018","journal-title":"Oncotarget"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/ng.985","article-title":"A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer","volume":"43","author":"Haiman","year":"2011","journal-title":"Nat. Genet."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1158\/0008-5472.CAN-11-3364","article-title":"19p13.1 is a triple-negative-specific breast cancer susceptibility locus","volume":"72","author":"Stevens","year":"2012","journal-title":"Cancer Res."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"9641","DOI":"10.1158\/0008-5472.CAN-10-0527","article-title":"An illegitimate microRNA target site within the 3\u2032 UTR of MDM4 affects ovarian cancer progression and chemosensitivity","volume":"70","author":"Wynendaele","year":"2010","journal-title":"Cancer Res."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/carcin\/bgt404","article-title":"Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer","volume":"35","author":"Purrington","year":"2014","journal-title":"Carcinogenesis"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Liu, C., Zhang, F., Li, T., Lu, M., Wang, L., Yue, W., and Zhang, D. (2012). MirSNP, a database of polymorphisms altering miRNA target sites, identifies miRNA-related SNPs in GWAS SNPs and eQTLs. BMC Genom., 13.","DOI":"10.1186\/1471-2164-13-661"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.3892\/mco.2015.648","article-title":"Promoter mutation of tumor suppressor microRNA-7 is associated with poor prognosis of lung cancer","volume":"3","author":"Zhao","year":"2015","journal-title":"Mol. Clin. Oncol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1038\/ng.3785","article-title":"Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer","volume":"49","author":"Milne","year":"2017","journal-title":"Nat. Genet."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.tcb.2010.01.009","article-title":"The p53 orchestra: Mdm2 and Mdmx set the tone","volume":"20","author":"Wade","year":"2010","journal-title":"Trends Cell. Biol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: Genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"D107","DOI":"10.1093\/nar\/gkm967","article-title":"ORegAnno: An open-access community-driven resource for regulatory annotation","volume":"36","author":"Griffith","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"D640","DOI":"10.1093\/nar\/gkp926","article-title":"Patrocles: A database of polymorphic miRNA-mediated gene regulation in vertebrates","volume":"38","author":"Hiard","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Hariharan, M., Scaria, V., and Brahmachari, S.K. (2009). dbSMR: A novel resource of genome-wide SNPs affecting microRNA mediated regulation. BMC Bioinform., 10.","DOI":"10.1186\/1471-2105-10-108"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"D86","DOI":"10.1093\/nar\/gkt1028","article-title":"PolymiRTS Database 3.0: Linking polymorphisms in microRNAs and their target sites with human diseases and biological pathways","volume":"42","author":"Bhattacharya","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1093\/carcin\/bgq128","article-title":"FGFR2 and other loci identified in genome-wide association studies are associated with breast cancer in African-American and younger women","volume":"31","author":"Shetty","year":"2010","journal-title":"Carcinogenesis"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/jnci\/djq563","article-title":"Novel breast cancer susceptibility locus at 9q31.2: Results of a genome-wide association study","volume":"103","author":"Fletcher","year":"2011","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"4340","DOI":"10.1073\/pnas.0800441105","article-title":"Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33","volume":"105","author":"Gold","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Hein, R., Maranian, M., Hopper, J.L., Kapuscinski, M.K., Southey, M.C., Park, D.J., Schmidt, M.K., Broeks, A., Hogervorst, F.B., and Bueno-de-Mesquita, H.B. (2012). Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC). PLoS ONE, 7.","DOI":"10.1371\/annotation\/e5de602c-0ffc-4e6f-a2ed-f79913c2e57c"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"R56","DOI":"10.1186\/bcr3158","article-title":"A genome-wide association study identifies a breast cancer risk variant in ERBB4 at 2q34: Results from the Seoul Breast Cancer Study","volume":"14","author":"Kim","year":"2012","journal-title":"Breast Cancer Res. BCR"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/ng.353","article-title":"A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1)","volume":"41","author":"Thomas","year":"2009","journal-title":"Nat. Genet."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/ng.586","article-title":"Genome-wide association study identifies five new breast cancer susceptibility loci","volume":"42","author":"Turnbull","year":"2010","journal-title":"Nat. Genet."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/ng.318","article-title":"Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1","volume":"41","author":"Zheng","year":"2009","journal-title":"Nat. Genet."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ajhg.2018.11.002","article-title":"Polygenic risk scores for prediction of breast cancer and breast cancer subtypes","volume":"104","author":"Mavaddat","year":"2019","journal-title":"Am. J. Hum. Genet."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/ije\/dyx242","article-title":"Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association Consortium","volume":"47","author":"Rudolph","year":"2018","journal-title":"Int. J. Epidemiol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nature24284","article-title":"Association analysis identifies 65 new breast cancer risk loci","volume":"551","author":"Michailidou","year":"2017","journal-title":"Nature"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1001\/jamaoncol.2016.1025","article-title":"Breast cancer risk from modifiable and nonmodifiable risk factors among white women in the United States","volume":"2","author":"Maas","year":"2016","journal-title":"JAMA Oncol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/16\/5835\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:00:47Z","timestamp":1760176847000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/16\/5835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,14]]},"references-count":109,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2020,8]]}},"alternative-id":["ijms21165835"],"URL":"https:\/\/doi.org\/10.3390\/ijms21165835","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,14]]}}}